XGN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 26.10%

Insider Buying (Last 12 Months): $145,866.97

Insider Selling (Last 12 Months): $684,417.44

Exagen Insider Trading History Chart

Exagen Share Price & Price History

^$5.15

▲ +0.44 (9.34%)

As of 12/20/2024 06:17 PM ET

Days: 30 | 90 | 365

$2 Trillion Disappears Because of Fed's Secretive New Move

From Stansberry Research | Ad

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.

Exagen Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/20/2024	Nmsic Co-Investment Fund, L.P.	Major Shareholder	Sell	200,000	$3.30	$660,000.00	2,108,958
11/14/2024	John Aballi	CEO	Buy	24,305	$2.81	$68,297.05	689,799
5/16/2024	John Aballi	CEO	Buy	40,401	$1.92	$77,569.92	40,401
3/4/2024	Kamal Adawi	CFO	Sell	12,784	$1.91	$24,417.44	243,749
10/17/2023	John Aballi	CEO	Sell	33,819	$1.75	$59,183.25	415,984
6/15/2023	James L.L. Tullis	Major Shareholder	Buy	167	$3.11	$519.37	1,515,839
2/8/2023	Mark Hazeltine	Insider	Sell	5,821	$2.69	$15,658.49	93,872
12/8/2022	John Aballi	CEO	Buy	90,000	$2.68	$241,200.00	440,000

WARNING: “Buffett Indicator” flashing for first time in 50 years

From Behind the Markets | Ad

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW

SEC Filings (Institutional Ownership Changes) for Exagen (NASDAQ:XGN)

75.25% of Exagen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Exagen Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/14/2024	Wasatch Advisors LP	490,205	$1.52M	0.0%	-35.7%	2.819%
11/14/2024	Stonepine Capital Management LLC	534,398	$1.65M	1.0%	+49.0%	3.073%
11/5/2024	Verus Capital Partners LLC	12,460	$39K	0.0%	N/A	0.072%
10/31/2024	Perkins Capital Management Inc.	458,871	$1.42M	1.3%	-7.0%	2.639%
10/28/2024	Palumbo Wealth Management LLC	76,364	$0.24M	0.1%	+14.5%	0.439%
10/11/2024	Creative Planning	35,500	$0.11M	0.0%	N/A	0.204%
8/21/2024	Stonepine Capital Management LLC	358,697	$0.65M	0.6%	-6.7%	2.063%
8/20/2024	Nantahala Capital Management LLC	59,316	$0.11M	0.0%	-20.2%	0.341%
8/9/2024	Renaissance Technologies LLC	94,234	$0.17M	0.0%	+93.3%	0.542%
8/9/2024	Dimensional Fund Advisors LP	21,039	$38K	0.0%	-20.4%	0.121%
8/7/2024	Cowen AND Company LLC	891,366	$1.62M	0.0%	-0.8%	5.131%
7/24/2024	Penbrook Management LLC	69,455	$0.13M	0.1%	-9.5%	0.400%
5/10/2024	Perkins Capital Management Inc.	493,571	$0.79M	0.7%	-3.0%	2.843%
4/18/2024	Wasatch Advisors LP	786,895	$1.25M	0.0%	-7.5%	4.564%
2/14/2024	Wasatch Advisors LP	850,308	$1.69M	0.0%	-0.7%	4.987%
2/14/2024	RTW Investments LP	1,504,602	$2.99M	0.0%	+0.8%	8.825%
2/13/2024	Stonepine Capital Management LLC	669,684	$1.33M	0.6%	-44.4%	3.928%
1/22/2024	Perkins Capital Management Inc.	508,905	$1.01M	0.9%	+92.8%	2.985%
11/14/2023	Stonepine Capital Management LLC	1,203,491	$2.91M	1.0%	+14.7%	7.138%
8/16/2023	Stonepine Capital Management LLC	1,049,352	$3.04M	1.1%	+1.2%	6.224%
8/14/2023	Silvercrest Asset Management Group LLC	547,133	$1.59M	0.0%	+8.9%	3.245%
8/11/2023	Stonepine Capital Management LLC	1,049,352	$3.04M	1.1%	+1.2%	6.224%
8/7/2023	Cowen AND Company LLC	842,376	$2.44M	0.2%	-10.7%	4.999%
7/21/2023	Perkins Capital Management Inc.	263,905	$0.77M	0.7%	+1.5%	1.566%
5/15/2023	RTW Investments LP	1,391,184	$3.38M	0.1%	+2.0%	8.256%
5/15/2023	Stonepine Capital Management LLC	1,037,074	$2.52M	0.8%	+21.4%	6.154%
5/9/2023	Cowen AND Company LLC	943,552	$2.29M	0.3%	-2.3%	5.600%
5/9/2023	Perkins Capital Management Inc.	259,905	$0.63M	0.6%	+3.0%	1.542%
4/25/2023	First Bank & Trust	16,793	$41K	0.0%	-23.5%	0.100%
2/13/2023	Platinum Investment Management Ltd.	264,130	$0.63M	0.0%	-24.8%	1.624%
2/9/2023	Cowen AND Company LLC	966,022	$2.32M	0.2%	-27.3%	5.941%
1/27/2023	First Bank & Trust	21,954	$53K	0.0%	-18.1%	0.135%
1/26/2023	Perkins Capital Management Inc.	252,405	$0.61M	0.6%	-2.0%	1.552%
1/24/2023	Penbrook Management LLC	74,010	$0.18M	0.2%	-14.9%	0.455%
11/15/2022	Platinum Investment Management Ltd.	351,071	$0.95M	0.0%	-12.2%	2.159%
11/14/2022	RTW Investments LP	1,048,662	$2.84M	0.1%	+2.3%	6.449%
11/10/2022	Nantahala Capital Management LLC	150,535	$0.41M	0.0%	-3.6%	0.926%
11/10/2022	Stonepine Capital Management LLC	1,265,373	$3.43M	1.5%	+0.4%	7.782%
11/1/2022	Brinker Capital Investments LLC	99,115	$0.27M	0.0%	+9.4%	0.610%
10/24/2022	Perkins Capital Management Inc.	257,455	$0.70M	0.8%	+8.6%	1.583%
8/16/2022	Intrust Bank NA	10,031	$57K	0.0%	N/A	0.062%
8/15/2022	Nantahala Capital Management LLC	156,135	$0.90M	0.0%	-2.0%	0.960%
8/5/2022	Cowen AND Company LLC	1,355,414	$7.78M	0.8%	-2.1%	8.338%
8/2/2022	Paradigm Capital Management Inc. NY	81,189	$0.47M	0.0%	+42.7%	0.499%
7/29/2022	Perkins Capital Management Inc.	236,975	$1.36M	1.4%	+17.9%	1.458%
7/22/2022	First Bank & Trust	23,176	$0.13M	0.0%	+47.1%	0.143%
7/22/2022	HighTower Trust Services LTA	2,683,578	$231.06M	24.2%	N/A	16.504%
7/18/2022	Brinker Capital Investments LLC	90,596	$0.52M	0.0%	-2.8%	0.557%
5/25/2022	Paradigm Capital Management Inc. NY	56,900	$0.46M	0.0%	+36.6%	0.350%
5/17/2022	RTW Investments LP	990,143	$7.95M	0.2%	+20.5%	6.089%
5/16/2022	Cooper Creek Partners Management LLC	153,468	$1.23M	0.1%	N/A	0.944%
5/10/2022	Advisors Capital Management LLC	39,769	$0.32M	0.0%	+6.0%	0.245%
5/5/2022	Russell Investments Group Ltd.	3,439	$27K	0.0%	N/A	0.021%
5/2/2022	Cowen Prime Advisors LLC	99,400	$0.80M	0.3%	-2.9%	0.612%
4/29/2022	First Bank & Trust	15,753	$0.13M	0.0%	+25.1%	0.097%
4/20/2022	Perkins Capital Management Inc.	200,975	$1.61M	1.3%	+0.8%	1.238%
2/16/2022	Wasatch Advisors Inc.	1,105,760	$12.86M	0.1%	+0.7%	6.841%
2/15/2022	Stonepine Capital Management LLC	858,567	$9.99M	4.6%	+119.8%	5.312%
2/14/2022	Maven Securities LTD	52,491	$0.61M	0.0%	-65.6%	0.325%
2/10/2022	Perkins Capital Management Inc.	199,475	$2.32M	1.6%	-3.3%	1.234%
2/9/2022	Paradigm Capital Management Inc. NY	41,666	$0.49M	0.0%	N/A	0.258%
2/8/2022	Brinker Capital Investments LLC	71,393	$0.83M	0.0%	-40.6%	0.442%
2/8/2022	Cowen Prime Advisors LLC	102,400	$1.19M	0.4%	-44.0%	0.634%
2/8/2022	Northern Trust Corp	89,553	$1.04M	0.0%	-3.3%	0.554%
2/4/2022	Envestnet Asset Management Inc.	23,892	$0.28M	0.0%	-9.3%	0.148%
2/1/2022	First Bank & Trust	12,597	$0.15M	0.1%	+46.3%	0.078%
1/28/2022	Allspring Global Investments Holdings LLC	3,016	$35K	0.0%	N/A	0.019%
1/20/2022	Parallel Advisors LLC	4,325	$50K	0.0%	-50.0%	0.027%
11/15/2021	Natixis	125,000	$1.70M	0.0%	N/A	0.775%
11/12/2021	Stonepine Capital Management LLC	390,637	$5.31M	2.4%	+130.4%	2.422%
11/12/2021	Wasatch Advisors Inc.	1,098,258	$14.94M	0.1%	-35.2%	6.810%
11/12/2021	Cowen AND Company LLC	1,384,631	$18.83M	0.9%	+90.7%	8.586%
11/12/2021	Geode Capital Management LLC	160,194	$2.18M	0.0%	+15.5%	0.993%
11/9/2021	BlackRock Inc.	583,888	$7.94M	0.0%	-0.3%	3.620%
11/8/2021	Russell Investments Group Ltd.	26,288	$0.36M	0.0%	-8.7%	0.163%
11/4/2021	Deutsche Bank AG	219,199	$2.98M	0.0%	-28.3%	1.359%
11/2/2021	Cowen Prime Advisors LLC	182,900	$2.49M	0.9%	N/A	1.134%
11/2/2021	New York State Common Retirement Fund	6,923	$94K	0.0%	-36.7%	0.043%
10/26/2021	Penbrook Management LLC	87,750	$1.19M	0.7%	N/A	0.544%
10/26/2021	Calamos Advisors LLC	11,768	$0.16M	0.0%	-56.6%	0.073%
10/25/2021	Perkins Capital Management Inc.	206,230	$2.81M	1.7%	+2.9%	1.279%
8/17/2021	Walleye Capital LLC	12,398	$0.19M	0.0%	N/A	0.077%
8/17/2021	Millennium Management LLC	76,058	$1.14M	0.0%	N/A	0.472%
8/17/2021	Bridgeway Capital Management LLC	77,500	$1.16M	0.0%	+3.3%	0.481%
8/16/2021	Nantahala Capital Management LLC	367,936	$5.52M	0.2%	-1.7%	2.281%
8/16/2021	California State Teachers Retirement System	14,849	$0.22M	0.0%	+105.7%	0.092%
8/16/2021	Morgan Stanley	364,864	$5.47M	0.0%	+269.1%	2.262%
8/16/2021	Maven Securities LTD	163,913	$2.47M	0.1%	-6.3%	1.016%
8/16/2021	Charles Schwab Investment Management Inc.	27,074	$0.41M	0.0%	+164.1%	0.168%
8/16/2021	State Street Corp	93,063	$1.40M	0.0%	+37.4%	0.577%
8/16/2021	Nuveen Asset Management LLC	30,980	$0.47M	0.0%	+172.0%	0.192%
8/16/2021	Silvercrest Asset Management Group LLC	310,198	$4.65M	0.0%	-0.4%	1.923%
8/16/2021	Goldman Sachs Group Inc.	10,189	$0.15M	0.0%	N/A	0.063%
8/13/2021	RTW Investments LP	821,414	$12.31M	0.2%	-49.5%	5.093%
8/13/2021	Northern Trust Corp	97,403	$1.46M	0.0%	+81.7%	0.604%
8/13/2021	Samjo Capital LLC	205,000	$3.07M	2.1%	+36.7%	1.211%
8/13/2021	Geode Capital Management LLC	138,750	$2.08M	0.0%	+67.3%	0.820%
8/13/2021	Vanguard Group Inc.	519,873	$7.79M	0.0%	+25.9%	3.071%
8/12/2021	Wasatch Advisors Inc.	1,693,678	$25.39M	0.1%	+0.1%	10.005%
8/12/2021	Dimensional Fund Advisors LP	14,160	$0.21M	0.0%	N/A	0.084%

Data available starting January 2016

Exagen Inc. develops and commercializes various testing products under the AVISE brand in the United States. The company enables healthcare providers to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). Its lead testing product is AVISE CTD that enables differential diagnosis for patients presenting with symptoms indicative of various connective tissue diseases (CTDs) and other related diseases with overlapping symptoms. The company offers AVISE Lupus that measures activation of the complement system by quantifying the level of B-cell C4d and erythrocyte bound C4d in the patient's blood; and AVISE APS, which consists of a panel of autoantibody tests that aids in the diagnosis and management of APS. In addition, it provides AVISE Vasculitis AAV, which utilizes a testing panel of individual analytes to provide physicians with results in the assessment and monitoring of anti-neutrophil cytoplasmic antibody associated vasculitis; AVISE SLE Prognostic, a panel of autoantibodies for assessing the potential for complications affecting the kidney, brain, and cardiovascular system; and AVISE Anti-CarP test, which identifies RA patients with severe disease. Further, the company offers AVISE SLE Monitor, a biomarker blood test; AVISE MTX, a patented and validated blood test; and AVISE HCQ, a blood test to monitor levels of hydroxychloroquine. It has a research collaboration and license agreement with Allegheny Health Network (AHN) Research Institute to develop novel patented biomarkers. The company was formerly known as Exagen Diagnostics, Inc. and changed its name to Exagen Inc. in January 2019. Exagen Inc. was incorporated in 2002 and is headquartered in Vista, California.

Today's Range

Now: $5.15

$4.72

$5.18

50 Day Range

MA: $3.62

$2.43

$6.00

52 Week Range

Now: $5.15

$1.30

$6.22

Volume

79,173 shs

Average Volume

55,508 shs

Market Capitalization

$90.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.49

Who are the company insiders with the largest holdings of Exagen?: Exagen's top insider investors include:
Nmsic Co-Investment Fund, LP (Major Shareholder)
James L L Tullis (Major Shareholder)
John Aballi (CEO)
Kamal Adawi (CFO)
Mark Hazeltine (Insider)
Learn More about top insider investors at Exagen.
Who are the major institutional investors of Exagen?: Exagen's top institutional investors include:
Stonepine Capital Management LLC — 3.07%
Wasatch Advisors LP — 2.82%
Perkins Capital Management Inc. — 2.64%
Palumbo Wealth Management LLC — 0.44%
Creative Planning — 0.20%
Verus Capital Partners LLC — 0.07%
Learn More about top institutional investors of Exagen stock.
Which major investors are selling Exagen stock?: During the previous quarter, XGN stock was sold by these institutional investors:
Wasatch Advisors LP
Perkins Capital Management Inc.
Within the previous year, company insiders that have sold Exagen company stock include:
Nmsic Co-Investment Fund, LP (Major Shareholder)
James L L Tullis (Major Shareholder)
Learn More investors selling Exagen stock.
Which major investors are buying Exagen stock?: Within the previous quarter, XGN stock was bought by institutional investors including:
Stonepine Capital Management LLC
Creative Planning
Verus Capital Partners LLC
Palumbo Wealth Management LLC
During the previous year, these company insiders have bought Exagen stock:
Nmsic Co-Investment Fund, LP (Major Shareholder)
James L L Tullis (Major Shareholder)
Learn More investors buying Exagen stock.